Literature DB >> 2671467

Hyperfiltration and renal disease in glycogen storage disease, type I.

L Baker1, S Dahlem, S Goldfarb, E F Kern, C A Stanley, J Egler, J S Olshan, S Heyman.   

Abstract

A prospective study of 14 patients (ages 6 months to 33 years) with glycogen storage disease, Type I (GSD-I) was carried out in order to define the character and frequency of renal dysfunction. A marked increase in the glomerular filtration rate (GFR) was documented in virtually all subjects, with the mean GFR raised by approximately 50%, to the range of 170 ml/min/1.73 m2. While this constituted the only renal abnormality found in the younger patients, a significant increase in urinary albumin excretion was seen in three teen-aged individuals; three patients over 20 years of age exhibited frank proteinuria (2 to 8 g/day). Renal biopsy on two of the proteinuric subjects revealed focal and global glomerulosclerosis and interstitial fibrosis. Evaluation of factors known to cause an increase in GFR did not define the precise etiology for its elevation in GSD-I. These studies suggest that: (1) glomerular damage and chronic renal disease are common in older patients with GSD-I; (2) the renal injury appears to be specifically related to GSD-I and is not secondary to the treatment of the disease; and (3) the natural history of the renal lesion in GSD-I may be analogous to that seen in insulin-dependent diabetes, with a "silent" period where hyperfiltration is the only demonstrable renal abnormality, followed by evidence of increasing glomerular damage progressing from microalbuminuria to frank proteinuria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671467     DOI: 10.1038/ki.1989.133

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Variability of renal length in type I glycogen storage disease.

Authors:  Y T Chen; K A Feinstein; R A Coleman; E L Effmann
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Renal function and kidney size in glycogen storage disease type I.

Authors:  W C Reitsma-Bierens; G P Smit; J A Troelstra
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

3.  In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.

Authors:  Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

Review 4.  Dietary dilemmas in the management of glycogen storage disease type I.

Authors:  Kaustuv Bhattacharya
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

Review 5.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

Review 6.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

7.  Glycogen Storage Disease Type I Presenting with Hypertension During Infancy.

Authors:  Eshita Bhowmik; Moumita Ghosh; Tapas Kumar Sabui; Rakesh Mondal
Journal:  Indian J Pediatr       Date:  2015-03-05       Impact factor: 1.967

8.  Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

Authors:  Xiaoyan Luo; Gentzon Hall; Songtao Li; Andrew Bird; Peter J Lavin; Michelle P Winn; Alex R Kemper; Talmage T Brown; Dwight D Koeberl
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

9.  Effective renal plasma flow in patients with glycogen storage disease type I.

Authors:  H Hahn-Ullrich; J Sciuk; P Bartenstein; P Kreysing; K Ullrich
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

10.  Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Authors:  N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.